# AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Subsidiary Partners With LUNR Aerospace to Advance AI-Driven Space Medicine

Fifty 1 Labs (OTC: FITY) announced that its subsidiary, Fifty 1 AI Labs, has entered into a partnership with LUNR Aerospace to develop AI-driven drug repurposing initiatives for space medicine. The collaboration will address key health challenges in microgravity, including immune support, musculoskeletal resilience, neuro-ocular protection, cardiovascular stability, cognitive performance, sleep optimization and metabolic longevity. Pilot programs will test AI-curated therapeutics and nutraceuticals in space-relevant conditions, offering a cost-efficient path to innovation. With the global space medicine market projected to grow from USD 948.7 million in 2025 to USD 1.97 billion by 2032 at an 11% CAGR, the partnership positions Fifty 1 Labs to capitalize on expanding demand while creating dual-use opportunities across aerospace, defense, longevity and precision health markets.

 To view the full press release, visit https://ibn.fm/H6u1k

 About Fifty1 AI Labs

 Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), is redefining drug discovery by using AI to unlock new potential in proven medicines. By repurposing safe, off-patent compounds, we accelerate smarter therapies that improve lives, reduce costs, and create lasting value for patients, partners, and forward-thinking investors.

 For more information, visit the company’s website at https://fifty1labs.com/

 About AINewsWire

 AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

 AINW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit www.AINewsWire.com

 Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

 AINewsWireAustin, Texaswww.AINewsWire.com512.354.7000 OfficeEditor@AINewsWire.com

 AINewsWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/ainw/ainewsbreaks-fifty-1-labs-inc-otc-fity-subsidiary-partners-with-lunr-aerospace-to-advance-ai-driven-space-medicine/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/fifty-1-labs-partners-with-lunr-aerospace-for-ai-space-medicine-breakthrough/eee0b71317281093bf25cea64c927dd0) 

 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1n0ou3m/fifty_1_labs_partners_with_lunr_aerospace_for_ai/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/258/26/kiwi6X72.webp)